Influence of KDR Genetic Variation on the Efficacy and Safety of Patients with Chemotherapy Refractory Metastatic CRC Who Received Apatinib Treatment

BACKGROUND: The aim of the present study was to investigate the influence of kinase insert domain containing receptor (KDR) genetic variation on the efficacy of treatment and safety of patients with chemotherapy-refractory metastatic colorectal cancer (CRC) receiving apatinib. METHODS: A total of 10...

Descripción completa

Detalles Bibliográficos
Autores principales: Bai, Ming, Li, Zhi-Guo, Ba, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006973/
https://www.ncbi.nlm.nih.gov/pubmed/33790633
http://dx.doi.org/10.2147/IJGM.S300968

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006973/
https://www.ncbi.nlm.nih.gov/pubmed/33790633
http://dx.doi.org/10.2147/IJGM.S300968

Ejemplares similares